Top Stories News
Top Stories news
-
News Rexahn Completes Patient Recruitment in Cancer Drug Trial
Rexahn Pharmaceuticals has completed enrollment for a Phase II clinical trial of its experimental cancer drug Archexin. -
News Evotec Takes over Full Ownership of JV in India
Evotec has agreed to acquire the remaining 30% of its Joint Venture with DIL Ltd., India for $2.3 million. -
News Japan's Santen to Acquire French Novagali
Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French biopharma Novagali. -
News Helsinn Healthcare & Riemser Arzneimittel Expand Licensing Agreement
Helsinn Healthcare and Riemser Arzneimittel signed an agreement to grant marketing rights in Germany to Riemser for a next-generation treatment in development for the prevention of chemotherapy-induced nausea and vomiting. -
News NIBRT Collaborates with GE Healthcare for Novel Analytical Platforms
The collaboration aims to develop new, robust and reproducible biochemical assays for the analysis of the biological activity of therapeutic monoclonal antibodies. -
News AmerisourceBergen to Acquire TheraCom for $250M
Pharmaceutical wholesaler AmerisourceBergen has agreed to buy TheraCom, a subsidiary of CVS Caremark, for $250 million. -
News Biotie Therapies to Acquire Newron for 45M
Finnish biotech Biotie Therapies will purchase Italian biopharmaceutical firm Newron Pharmaceuticals for 45m. -
News Lonza & Mesoblast Ink Manufacturing Pact for Stem Cell Products
Lonza has entered into a strategic alliance with Australia-based Mesoblast for the production of Mesoblast's adult stem cell therapies. -
News PCCA Urges Member Pharmacists to Offer Solutions for Drug Shortages
PCCA President urges member pharmacists to continue their efforts to reduce the growing issue of drug shortages. -
News Merck Opens R&D Facility in Ireland
Six drugs are currently in development at the facility, including Merck's candidate drug for the treatment of hepatitis C and a dual high cholesterol/type II diabetes medication. -
News SK Biopharmaceuticals with Mayo Clinic for Sclerosis Drug Development
The South Korean biotech forms a partnership with Mayo Clinic to focus on research into chemical compounds that target a type of protein known as TDP-43. -
News Loxbridge with Nobel Prize Winner to Combat Superbugs
Loxbridge Research signed a joint venture agreement to form Altermune Technologies to develop new therapeutics targeting combat resistant pathogens. -
News BMS & Ambrx Form Collaboration in Two Therapeutic Areas
New York-based Bristol-Myers Squibb has inked an agreement with Ambrx to research, develop and commercialize biologics based on Ambrx's research surrounding the Fibroblast Growth Factor 21 protein and the Relaxin hormone. -
News India's Drug Regulators to Send Delegation to Inspect Manufacturing Sites in China
This will be the second auditing and inspection of manufacturing facilities in China. The CDSCO delegation inspected five manufacturing sites in China in May which have been found to be in good condition. -
News Lilly Invests $30M in Partnership to Address Chronic Diseases
The partnership will initially focus on diabetes - a core business area in which Lilly has deep expertise. -
News BMS Inks Cancer Drug Pact with Japanese Pharma
Ono Pharmaceutical, based in Osaka, has granted BMS exclusive rights to develop and sell the potential cancer treatment worldwide except in Japan, Korea and Taiwan. -
News Sanofi Pasteur Announces R&D Collaboration for Skin Disease Treatment
Sanofi Pasteur has announced a research and development collaboration with the University of California on an immunological approach to acne prevention and treatment. -
News India Forms 12 New Drug Advisory Committees
The 12 New Drug Advisory Committees will advise the Drugs Controller General of India in matters for review of applications of new drugs and clinical trials. -
News EMA Supports World Alzheimer's Day
To date, a total 11 medicines for use in patients with Alzheimer's disease have been authorised in the EU on the recommendation of the EMA. -
News Roche Partially Halts Drug Supplies to Greek Hospitals
Some state-funded hospitals in Italy and Portugal are also failing to pay their bills, and Roche has warned that drug deliveries may also be halted in Spain for the same reason. -
News Teva & Cocrystal Discovery Ink Antiviral Pact
Teva will initially invest $7.5 million in CDI for the development of an antiviral drug targeting the polymerase enzyme of the hepatitis C virus. -
News Chesapeake Acquires Cortegra to Expand US Pharma Market
Chesapeake Pharmaceutical and Healthcare Packaging has agreed to buy Cortegra Group, a US-based contract producer of packaging and leaflets. -
News GlaxoSmithKline Forms Partnership with McLaren
GSK has formed a five-year partnership with Formula 1 team McLaren to drive its manufacturing operations and research. -
News Novo Nordisk Launches Programme in India for Children with Diabetes
The programme, known as Changing Diabetes in Children, aims to reach over 2500 kids with type I diabetes from underprivileged families over the next two years. -
News Genentech Submits NDA for Skin Cancer Drug Vismodegib
Biotechnology firm Genentech has submitted a NDA for vismodegib to the FDA for the treatment of advanced basal cell carcinoma. -
News Spaulding Clinical & Frontage Labs Form Partnership for Clinical Development
Frontage will provide bioanalytical method development and sample processing, formulation development and clinical trial product supplies for Spaulding. -
News Debiopharm Signs Licence Agreement with Ascenta for Cancer Drug
The two companies have signed an exclusive licence agreement for the development and commercialization of a tumours treatment currently in Phase I development. -
News India's Aurobindo Forms JV with OJSC Diod for Russian Market
The joint venture, named Aurospharma, will include a manufacturing facility near Moscow, due to be completed in 2013. -
News UK-based Pharma Firms Ink Deal for Cancer Drug Programme
Under the agreement, Ark will provide manufacturing and related services to support the development of PsiOxus ColoAd1 programme for the treatment of colorectal cancer. -
News Sucampo & Numab Enter into Discovery Collaboration for Antibodies
Sucampo Pharmaceuticals signs an R&D collaboration deal with Numab for the discovery of antibodies using the latter's high-affinity antibody technology. -
News Cuba Distributes First Lung Cancer Vax in Hospitals without Charge
Cuban medical authorities have launched the distribution of CimaVax-EGF, the world's first lung cancer vaccine, in Cuban hospitals free of charge. -
News Alchemia Starts Phase II Trial in Small Cell Lung Cancer
This study will examine the effectiveness of HA-Irinotecan, which utilizes Alchemia's technology to target the anti-cancer drug irinotecan to the tumor. -
News HCN2 Gene Gives Hope to Treat Chronic Pain
Researchers has identified a gene responsible for chronic back pain. -
News Lung Disease Therapy Esbriet to be Launched in Germany
Esbriet will be commercially available in Europe for the first time since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis. -
News BMS Completes Acquisition of Amira
Bristol-Myers Squibb has completed its previously announced acquisition of small-molecule pharmaceutical company Amira Pharmaceuticals. -
News HHS Awards $94M to GSK for New Antibiotic Development
GlaxoSmithKline will receive $94m from the US Department of Health and Human Services for a promising new antibiotic research and testing. -
News Germany to Invest Billions for Healthcare Research
The new programme will provide a boost to bringing research results rapidly to market, according to Germany Trade & Invest. -
News BioLineRx Signs License Deal for Pain Treatment BL-7050
BioLineRx announced yesterday its worldwide, exclusive license agreement with Ramot at Tel Aviv University for a neuropathic and inflammatory pain treatment. -
News Merck Serono & F-Star Collaborate for Novel Targeted Biologics
Austria's F-Starfor announced yesterday the agreement with Merck Serono for the discovery of new antibody-derived therapeutics against inflammatory disease targets. -
News Evotec & Roche Ink Alzheimer's Pact
Evotec and Roche have teamed up to develop and commercialize MAO-B inhibitor of Evotec for the patients with Alzheimer's disease. -
News WHO & FIP Sign Landmark Initiative for Tuberculosis Care Improvement
The WHO and the FIP signed a joint statement seeking to involve pharmacists in tuberculosis care and control. -
News Addex Regains Parkinson's Programme Rights from Merck
Merck originally licensed the rights to the programme in 2007 in a deal potentially worth as much as $170.5m. -
News Pfizer & Sanofi Sign Deal for Generic Lipitor
Pfizer has granted Sanofi a licence to manufacture a generic version of the product and launch it after Lipitor's patent expires in the country on 7 May 2012. -
News Oxford Pharmascience Licenses Colonic Drug Delivery Technology
Oxford Pharmascience partners with University of London to have the option to license and research an advanced colonic drug delivery technology. -
News AstraZeneca's Crestor Fails to Best Lipitor in Study
According to trial results announced recently, Crestor, the statin drug from AstraZeneca, failed to best Lipitor at clearing clogged arteries. -
News Pfizer Inks Lease Deal with MIT for New Research Center
The new research site will be Pfizers Cardiovascular, Metabolic and Endocrine Disease (CVMED) and Neuroscience Research Units. -
News Pfizer & Dr Reddy's Settle Lipitor Patent Lawsuit
Pfizer, the worlds largest drugmaker, settles a lawsuit with the Indian generic-drug maker Dr. Reddys Laboratories over the cholesterol treatment Lipitor. -
News Teva Inks Cancer Pact with UK's Sinclair IS
Teva has signed an agreement with Sinclair IS to gain exclusive commercialisation rights of oncology medication Episil in Germany, Spain, Poland, Switzerland and the Czech Republic. -
News Bayer Healthcare to Acquire Pathway Medical Technologies
Bayer HealthCare's affiliate, MEDRAD, Inc. acquires Pathway Medical Technologies to strengthen its MEDRAD Interventional business by expanding its presence in the field of vascular intervention technologies. -
News OXiGENE to Restructure to Focus Clinical Resources on Earlier Stage Development Programs
Biopharmaceutical firm OXiGENE, Inc. decides to restructure in an to focus resources on its most promising early-stage clinical programs. -
News Pfizer Extends Tender Offer to Acquire Icagen
Pfizer's subsidiary, Eclipse Acquisition Corp. , has extended the expiration date of its tender offer for Icagen. -
News BMS Chooses ICON as Provider for Clinical Services
Under the agreement, ICON will become a preferred provider for full-service clinical pharmacology and exploratory clinical studies. -
News Valeant to Acquire Afexa for $76M
Valeant Pharmaceuticals will acquire cold and flu medicine maker Afexa Life Sciences for approximately $76 million. -
News Survey: US Hospitals Turn to Gray-market Vendors as Drug Shortage Continues
The study of 549 hospitals indicates that 52% of respondents purchased one or more pharmaceutical products from back-door suppliers during the past two years. -
News Adimab Forms Discovery Collaborations with Biogen & Novo Nordisk for Antibodies
Adimab will receive upfront payments and preclinical milestones from both companies, and is eligible to receive clinical development milestones and royalties on sales. -
News Merck & Zymeworks Ink $187M Deal for Bispecific Antibody
Under terms of the deal, Zymeworks will receive an up-front fee and could earn research, development, and regulatory milestones of up to $187 million. -
News India's Piramal to Invest $1.5B in Overseas Pharma Business
India's Piramal plans to invest at least $1.5 billion in biotech acquisitions and Big Pharma joint ventures to expand its overseas business. -
News Eisai to Expand Operations in Canada
Eisai will establish its Canadian headquarters in Mississauga, Ontario and the expansion into Ontario will increase access to a variety of therapies and medications. -
News UK Starts Probe into AstraZenca's Drug Mix-up
British health authorities warned that packages of an over-the-counter painkiller were found to contain antipsychotic drugs. -
News Cresset & Redx Pharma Form Drug Discovery Collaboration
Two UK firms have agreed to collaborate on drug discovery. -
News CPHI China 2011 Interview: Ms. Yu Lingmin, Manager of NO.1 Pharmaceutical Dept, A.H.A International CO., LTD
The CPHI, ICSE & BioPh China 2011 and P-MEC China 2011 were held in Shanghai from June 21, 2011 to June 23, 2011. During the exhibition, CPHI-Online had an interview with Ms. Yu Lingmin, Manager of NO.1 Pharmaceutical Dept, A.H.A Internatio... -
News Sanofi to Buy India's Universal Medicare
Sanofi announced to acquire India's nutraceuticals company Universal Medicare. The transaction is expected to close in the fourth quarter of this year. -
News Scotland's Research Organisations Collaborate for Drug Formulations Development
The combination of two research organisations will enable them to offer integrated pharmaceutical and clinical development solutions. -
News HHS Awards $137M to States for Public Health Investment
The HHS has announced the award of $137 million of grants to states to fund prevention and health improvement services and programs. -
News Spaulding & Clinigene Form Partnership for Clinical Pharmacology Services
Indian Clinigene International Ltd. and U.S. Spaulding Clinical Research will cooperate to develop their clinical pharmacology services. -
News Catalent To Buy Aptuit's CTS Business
Catalent Pharma Solutions announced that it will buy the clinical trial supplies business of Aptuit LLC for $410 million. -
News PBS Biotech Acquires Integrity CMI
The two companies will reconfigure their assets and personnel to maximize design and engineering operations and build out their manufacturing facilities. -
News WuXi's BAS Unit Receives Bioanalytical GLP Certification
The certificate states that WuXi's BAS facility in Shanghai is able to carry out ADME, toxicokinetic and pharmacokinetic studies, and hERG assay and biomarker studies with respect to OECD and EU GLP principles. -
News Bend Research & Xcelience Ink Drug Development Deal
The collaboration will combine Bends formulation/processing expertise for delivering poorly soluble compounds with Xceliences early-phase development expertise. -
News Par Pharmaceutical To Acquire Anchen for $410M
Par Pharmaceutical Companies said it has agreed to acquire privately-held Anchen Pharmaceuticals for $410 million in cash. -
News Study: Majority of Pharma Ads Not Comply with FDA Norms
The study found that of 192 pharmaceutical adverts, only 18% were compliant with the US FDA guidelines. -
News Novo Nordisk to Build New Corporate Centre
With the new premises, Novo Nordisk will be consolidating a number of administrative functions currently scattered across Greater Copenhagen. -
News Study Focuses on Drug Delivery Innovations
A study estimates that needle-free drug delivery methods will have annual revenue growth of 15.1% on average from 2011 to 2016 to reach US$6.2bn. -
News Takeda Receives Subsidy to Develop Influenza Vaccine
Takeda will have a JPY23.9bn (US$312m) government subsidy to develop a new influenza vaccine. -
News Par & Intellipharmaceutics Expand ADHD Pact
The two pharma firms have added the development and commercialization of additional strengths of generic Focalin XR for the U.S. market to their existing agreement. -
News Boehringer Ingelheim & ProBioGen Sign Licensing Agreement for Antibody Technology
Boehringer Ingelheim will apply ProBioGen's technology to enhance ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) activity of antibodies. -
News Paladin Labs to Acquire Labopharm
Paladin Labs will purchase drug technology developer Labopharm in a deal valued at over $20.4 million. -
News Roche Relaunches Arthritis Drug in UK
Roche's Toclizumab is already licensed to treat adults with severe arthritis, but as of today the drug will be available for children. -
News Survey Reveals Business Concerns of Healthcare Companies
According to the survey, changes in healthcare legislation and reform top the list of business concerns of healthcare companies in the US and Asia. -
News Carlyle in Talks to Buy PPD
Carlyle Group is in exclusive talks to buy North Carolina-based CRO company Pharmaceutical Product Development. -
News Swiss Biopharma 4-Antibody Partners with HGS
Swiss firm 4-Antibody inked a collaboration agreement with Human Genome Sciences for the discovery and development of fully human antibodies. -
News GE Healthcare to Buy PAA Laboratories
The acquisition expands GE Healthcares offering of products and services for cell biology research and the discovery and manufacture of biopharmaceuticals. -
News Pfizer Pays Compensation to Drug Trial Victims
The company has paid $175,000 to four families in the first of a series of payments as part of an out-of-court settlement reached in 2009. -
News Bayer Donates Moxifloxacin to WHO for TB Programme in China
Bayer HealthCare will support WHO and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis by making 620,000 tablets of the antibiotic moxifloxacin available to WHO. -
News Pfizer Forms Partnership with University of California for Drug Development
Pfizer has partnered with the University of California's San Diego Health Sciences in a drug discovery collaboration. -
News Biotech M&A Jumps in First Half
According to a new report focused on M&A activity, 18 biotech companies were sold during the first half of this year for total upfront values of $51.6 billion. -
News CPHI China 2011 Interview: Mr. Zhou Jianmin, Board Member /Deputy GM of Liaocheng Wanhe Industrial Manufacture Co., Ltd.
The CPHI, ICSE & BioPh China 2011 and P-MEC China 2011 were held in Shanghai from June 21, 2011 to June 23, 2011. During the exhibition, CPHI-Online had an interview with Mr. Zhou Jianmin, Board Member /Deputy General Manager of Liaocheng W... -
News Teva Allowed to File NDA for Rhinitis Therapy
The approval follows the results from two Phase III trials assessing the safety and efficacy of BDP Nasal HFA in the treatment of SAR and PAR. -
News Russian Pharmaceutical Firms Collaborate for Innovative Treatments
The project will focus on developing treatments across three technological platforms. -
News GNS Healthcare with BMS to Identify Biomarkers in Immuno-inflammation
GNS will use clinical and molecular information from a Bristol-Myers Squibb clinical trial to build computer models to identify key molecular mechanisms. -
News Zydus & Zynesher Complete K-V Generics Acquisition for $60M
The acquisition covers K-V Pharma's certain packaging, manufacturing and laboratory facilities, as well as equipment specific to the generic business. -
News India's CMO Ipca Acquires UK's Onyx Scientific
Ipca said its UK subsidiary has acquired Onyx Research Chemicals, the holding company of Onyx Scientific Ltd, a contract manufacturing organisation. -
News Unigene & GSK Ink Pact for the Treatment of Osteoporosis in Postmenopausal Women
Unigene will receive up to approximately $2.2 million in milestone payments from GSK to undertake certain development and manufacturing activities. -
News NICE Recommends against Novartis Multiple Sclerosis Drug for NHS Patients
The UK's healthcare regulators have recommended against the prescription of Novartis' multiple sclerosis drug Gilenya to NHS patients due to uncertainties over its clinical effectiveness. -
News Researchers Work on Improving Influenza Vaccination for Broader Protection
From a public health perspective, an ideal influenza vaccine would protect against multiple strains of the virus, regardless of their hemagglutinin structure. -
News Spaulding Clinical & Eurofins Optimed Announce Joint Partnership for Global Studies
The partnership will leverage the strengths of both companies and facilitate collaboration on integrated clinical services to engage pharmaceutical clients who demand a global footprint. -
News MolMed Signs with GSK for Gene Therapy Development
Under the agreement, MolMed will develop a production process for an investigational gene therapy for ADA-SCID, a very rare disease that affects approximately 350 children worldwide. -
News US Drug Approvals in 2011 Reach 2010 Total
The number of drug approvals is set to increase further, with more than a dozen drug candidates still scheduled for review before the end of the year. -
News Pfizer Looks to Sell OTC Version of Lipitor
Pfizer hopes to sell an over-the-counter version of its best-selling drug Lipitor when its generic forms are available in November. -
News Vectura Signs Collaboration Agreement for Combination Therapy VR315
Vectura Group has inked a new US partnership deal for its generic lung drug VR315. -
News Merck & Serum Sign for Pneumococcal Vaccine
Under the terms of the agreement, Merck will receive specific rights to market PCV in certain designated territories and Serum will receive specific rights in other territories. -
News Acceleron & Celgene Form Collaboration for Anemia Treatment
Celgene and Acceleron will jointly develop, manufacture and commercialize ACE-536, a novel protein therapeutic for the treatment of anemia. -
News Merck and Novartis Top Drug-approval Rankings
Swiss drugmaker Novartis racked up 17 new drug approvals from 2000 to 2010. But over the past 60 years, the company has accounted for only 16. -
News KKR Buys Pfizers Capsugel for US$2.4B
Capsugel will maintain a corporate presence in the US. All Pfizer employees currently dedicated to this business will be transferred to Capsugel. -
News FDA and Its Counterparts Release Drug Inspection Collaboration Reports
The pilot programs are part of the FDA's global strategy to ensure the safety and quality of imported products. -
News Pfizer Reports Financial Results for Q2
The New York-based pharma company has reported its second quarter financial results. -
News Ariad and Merck Submit Ridaforolimus MAA
Merck is planning global submissions for ridaforolimus in Europe, the U.S., Canada, Asia-Pacific and Latin America and other key markets. -
News Study Focuses on Population Misusing Opioids
A new study says more than half the people who take opioids for chronic pain are likely to still be taking the painkillers five years later. -
News Merck to Make Further Job Cuts
As part of the next phase of its restructuring programme, Merck expects to reduce its workforce by an additional 12 to 13% by the end of 2015. -
News India and EU Reach Settlement on Indian Generic Drug Shipments
The settlement will ensure that none of the 27 members of the economic and trading bloc will detain 'Made in India' consignments of generic medicines, which are transiting through EU ports. -
News Bayer Reports Strong First-Half Sales in North America
Total first half sales in North America were EUR 4,393 million, an increase of 5.1 percent compared with first-half 2010 sales. -
News Russia to Focus on API Production Conquest
Russia's $1.3 billion federal program for the development of the pharmaceutical industry will help to persuade companies to buy APIs in Russia instead of India or China. -
News Flu Vaccine Production Will Double by 2015 to 1.7B Doses
According to the World Health Organization, the world's seasonal flu vaccine production capacity will double by 2015. -
News INC Research & Debiopharm Form Partnership for Clinical Development
Under the partnership, INC Research agrees to work with Debiopharm on future clinical studies. -
News GSK Announces 2Q11 Financial Results
GlaxoSmithKline reports its financial results for the second quarter ended June 30, 2011. -
News CPHI China 2011 Interview: Mr. Chen Yuming, General Manager of Chengdu GELAIPU SCI & TECH, CO., LTD
The CPHI, ICSE & BioPh China 2011 and P-MEC China 2011 were held in Shanghai from June 21, 2011 to June 23, 2011. During the exhibition, CPHI-Online had an interview with Mr. Chen Yuming, General Manager of Chengdu GELAIPU SCI & TECH, CO., ... -
News EMA Agrees to Recall of Vimpat Syrup
The EMA has agreed to a recall of Vimpat 15 mg/ml syrup because of a quality defect in some batches. -
News Genesis Biopharma and Lonza Sign Agreement for Metastatic Melanoma Treatment
Lonza is in partnership with Genesis Biopharma to develop Genesis Biopharma's autologous cell therapy product candidate for the treatment of Stage IV metastatic melanoma. -
News Vietnam to Test GSK Drug for Plasticizers
At the time of the Hong Kong recall, GSK and health officials there emphasized that the amounts of plasticizer found weren't likely to cause harm to humans if they were taken at the proper doses. -
News Roche to Provide Tests for Early Diagnosis of HIV-infected Infants in SA
Roche will deliver diagnostics to support the largest infant testing initiative in the world that aims to identify HIV-infected children during the first months of life.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance